InvestorsHub Logo
Followers 10
Posts 174
Boards Moderated 0
Alias Born 10/30/2020

Re: None

Saturday, 09/25/2021 12:22:02 PM

Saturday, September 25, 2021 12:22:02 PM

Post# of 199145
Riin Ehin, CEO @ Bravo Healthcare AS.

Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance.
Substanitial knowledge about the subject, strong partners outside EU for testing the outcomes globally in different environments

Looking forward to hear from her on Thursdays call.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News